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Identification of precise bleeding sites is generally important to control 
haemorrhage. Nevertheless, the optimal technique to detect the bleeding sites has not 
yet been fully defined for patients with life-threatening postpartum haemorrhage. We 
describe that ultrasonographic visualisation of bleeding sites can help control 









  Postpartum haemorrhage (PPH) is the most important cause of maternal 
death worldwide (1). PPH is largely caused by uterine atony (1).. Clinical evaluation, 
usually in combination with ultrasound examination, identifies an underlying cause 
of PPH, such as uterine atony, uterine inversion, or retained products of conception. 
Nevertheless, intractable PPH can sometimes occur with seemingly unknown causes, 
and the bleeding resists conventional conservative treatments. The key to 
management of intractable PPH is to identify the cause of bleeding and to initiate 
appropriate intervention immediately. We found that intrauterine balloons could be 





A 32-year-old nulliparous woman underwent caesarean section at 37 weeks 
of gestation due to severe preeclampsia and breech presentation. Two hours after 
surgery, a boggy uterus was observed, and approximately 650 g clots were expelled 
  
3 
from the uterine cavity. The uterus became firm and well contracted following 
evacuation of all uterine contents. However, the bleeding (130 g/hour) persisted, and 
the accumulation of clots (430 g) in the uterine cavity recurred within two hours 
despite the administration of uterotonic drugs, including oxytocin (20 units), 
methylergonovine maleate (0.2 mg), and oral misoprostol (400 µg). Her blood 
pressure was 144/98 mmHg; pulse, 88 beats per minute. Laboratory data were as 
follows: haemoglobin 10.5 g/dl, haematocrit 32.0%, and platelet count 191x109/l. 
Type 2 uterine bleeding (2), which seemingly presented with uterine atony, was 
strongly suspected from clinical manifestation. As Type 2 uterine bleeding is typified 
by bleeding from a disrupted artery at the upper part of the uterus (2), trans-abdominal 
Colour Doppler ultrasound examination (Voluson S8, convex transducer [2-5 MHz[; 
GE Healthcare, Milwaukee, WI) was conducted to explore bleeding sites. Active 
arterial bleeding was readily visualised from the posterior part of the upper uterine 
cavity (Figure 1). A Bakri balloon was then placed in the upper part of the uterus and 
was inflated with 350 mL of normal saline. An ultrasound confirmed that the surface 
of the balloon tightly compressed the bleeding vessel (Figure 2). Despite temporary 
control of bleeding (less than 30 minutes), recurrent uterine bleeding occurred due to 
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displacement of the intrauterine balloon towards the vagina. Consistently, active 
arterial bleeding was seen again using ultrasonography. Therefore, the Bakri balloon 
was reinserted into the uterine cavity, and each side of the uterine cervix was 
clamped with forceps, as previously reported (3). The balloon remained properly 
positioned within the uterine cavity, and the bleeding stopped. The amount of 
post-operative blood loss was 1300g, and a blood transfusion was not needed. 
 
Discussion 
PPH is the leading cause of maternal mortality (1). Persistent uterine 
bleeding with seemingly unknown causes can be classified into three types: Type 1, 
bleeding from a disrupted artery at the lower part of the uterus; Type 2, bleeding 
from a disrupted artery at the upper part of the uterus; and Type 3, bleeding due to 
uterine atony (2). Uterine bleeding of Type 1 and Type 2 is not stopped by uterotonics 
alone, while Type 3 is successfully controlled with uterotonic agents. Although both 
Types 2 and 3 have long been categorised as “uterine atony”, Type 2 bleeding, a 
subtype of conventional “uterine atony” in intractable PPH, cannot be resolved by 
the enhancement of uterine contractions alone. According most common protocols, 
  
5 
after use of uterotonic drugs, placement of a Bakri balloon is indicated. However, the 
Bakri balloon fails to control bleeding in 12.5% of PPH (4), probably partially due to 
failure of direct compression of the bleeding site by balloon tamponade. 
Identification of the precise bleeding site is therefore important to manage intractable 
PPH. Although the sites of active bleeding can be detected on gray scale and color 
Doppler imaging (5,6), the usefulness of ultrasound assessment of uterine bleeding 
sites has not been reported in the context of management of intractable PPH due to 
uterine atomy. The present case shows that prompt conservative intervention using a 
Bakri balloon in combination with ultrasonographic visualisation of bleeding sites 
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Figure Legends  
Figure 1. Ultrasonographic visualisation of uterine bleeding site. 
Trans-abdominal Colour Doppler ultrasound image shows a jet (arrow) of blood flow 
(upper panel), and duplex Doppler ultrasound image demonstrates low-resistance 
type of arterial blood flow (arrowhead) towards the cavity from the posterior part of 
the uterus (lower panel). 
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Figure 2. Ultrasonographic confirmation of Bakri balloon placement into the upper 
part of the uterine cavity (solid lines are added to show the outline of the uterus), 
where the bleeding vessel (arrow) was tightly opposed by the surface of the balloon 
(dashed line). 
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